These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 475865)

  • 1. Thymidine 5'-O-pivaloate. A prodrug derivative of thymidine with potential applications in high-dose methotrexate therapy.
    Ensminger WD; Rosowsky A
    Biochem Pharmacol; 1979 May; 28(9):1541-5. PubMed ID: 475865
    [No Abstract]   [Full Text] [Related]  

  • 2. The reversal of methotrexate toxicity by thymidine with maintenance of antitumour effects.
    Tattersall MH; Brown B; Frei E
    Nature; 1975 Jan; 253(5488):198-200. PubMed ID: 1078601
    [No Abstract]   [Full Text] [Related]  

  • 3. Methotrexate-thymidine treatment of murine leukemia.
    Tattersall MH; Brown BL; Frei E
    Ann N Y Acad Sci; 1975 Aug; 255():261-5. PubMed ID: 1081356
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation of the antitumor activity of methotrexate by concurrent infusion of thymidine.
    Semon JH; Grindey GB
    Cancer Res; 1978 Sep; 38(9):2905-11. PubMed ID: 679199
    [No Abstract]   [Full Text] [Related]  

  • 5. Some observations on the reversibility of methotrexate toxicity in normal proliferating tissues.
    Straw JA; Talbot DC; Taylor GA; Harrap KR
    J Natl Cancer Inst; 1977 Jan; 58(1):91-7. PubMed ID: 299894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells.
    Piper AA; Nott SE; Mackinnon WB; Tattersall MH
    Cancer Res; 1983 Nov; 43(11):5101-5. PubMed ID: 6616448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth rate and cell kill.
    Hryniuk WM; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():330-42. PubMed ID: 5289425
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation versus rescue of antimetabolite toxicity by salvage metabolites administered by continuous infusion.
    Grindey GB; Semon JH; Pavelic ZP
    Antibiot Chemother (1971); 1978; 23():295-304. PubMed ID: 306219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidine 5'-O-pivaloate: evidence for prodrug action in the rat and rhesus monkey.
    Rosowsky A; Wright JE; Steele G; Kufe DW
    Cancer Treat Rep; 1981; 65(1-2):93-9. PubMed ID: 7226169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
    Nederbragt H; Uitendaal MP; van der Grint L; Leyva A; Pinedo HM
    Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
    Eleff M; Franks PE; Wampler GL; Collins JM; Goldman ID
    Cancer Treat Rep; 1985; 69(7-8):867-74. PubMed ID: 2410122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of allopurinol on the therapeutic efficacy of methotrexate.
    Grindey GB; Moran RG
    Cancer Res; 1975 Jul; 35(7):1702-5. PubMed ID: 1131828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of resistance to methotrexate in L1210 murine leukemia by uracil.
    Wallerstein H; Slater LM; Eng B; Calman N
    Blood; 1971 Nov; 38(5):648-56. PubMed ID: 5094586
    [No Abstract]   [Full Text] [Related]  

  • 14. New approaches to cancer chemotherapy with methotrexate.
    Frei E; Jaffe N; Tattersall MH; Pitman S; Parker L
    N Engl J Med; 1975 Apr; 292(16):846-51. PubMed ID: 1078714
    [No Abstract]   [Full Text] [Related]  

  • 15. The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.
    Kline I; Venditti JM; Mead JA; Tyrer DD; Goldin A
    Cancer Res; 1966 May; 26(5):848-52. PubMed ID: 5934795
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
    Samuels LL; Straw JA
    Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of in vivo methotrexate antitumor effect in L1210 leukemia by induced impairment of purine salvage.
    Browman GP; Csullog GW
    Biochem Pharmacol; 1981 Apr; 30(8):869-74. PubMed ID: 7195709
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of 6-thioguanine cytotoxic activity with methotrexate.
    Armstrong RD; Vera R; Snyder P; Cadman E
    Biochem Biophys Res Commun; 1982 Nov; 109(2):595-601. PubMed ID: 7181934
    [No Abstract]   [Full Text] [Related]  

  • 19. [L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].
    Pouillart P; Huong TH; Lhéritier J
    Bull Cancer; 1974; 61(4):509-26. PubMed ID: 4458834
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of methotrexate on the leukemic cell cycle in mouse ascitic leukemia L1210].
    Goncharova SA; Frankfurt OS
    Tsitologiia; 1975 Sep; 17(9):1051-6. PubMed ID: 1166521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.